Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population (MINOCA-TR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03364387|
Recruitment Status : Recruiting
First Posted : December 6, 2017
Last Update Posted : March 7, 2018
|Condition or disease|
|Acute Coronary Syndrome Myocardial Infarction Atrial Fibrillation Diabetes Mellitus|
Acute coronary syndrome is leading causes of death worldwide. Although, >90% of these patients had of culprit coronary lesion, a significant proportion of them had no any angiographic evidence of obstructive coronary arteries. Exact mechanism of the myocardial infarction remains unclear of these patients. However, MI registries have reported that the 5% to %10 of MI patients have no evidence of obstructive coronary artery disease.
There is lack of any data regarding prevalence, demographics, patients' profile, management, and outcome of this clinical entity in Turkish population. This registry aims to obtain these data in Myocardial Infarction with Non-obstructive Coronary Artery Disease patients in Turkish population.
Although there are huge data in this issue from different country and geographic areas, to date no any national data about prevalence, demographics, management and in-hospital outcomes of AF patients who admitting with cute coronary syndrome. With this rationale the registry also aims to obtain demographics, clinical profile, management, and in-hospital outcome of AF in Turkish Acute coronary syndrome population.
|Study Type :||Observational|
|Estimated Enrollment :||4200 participants|
|Official Title:||The Clinical Profile, Management and Long-Term Outcomes of Patients With Acute Coronary Syndrome and Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population|
|Actual Study Start Date :||March 5, 2018|
|Estimated Primary Completion Date :||September 1, 2018|
|Estimated Study Completion Date :||November 15, 2018|
- Composites of Myocardial Infarction, Hospitalization, Revascularization, Death [ Time Frame: 12 months ]Re-infarction, Any cause or Cardiovascular Hospitalization or Death
- Atrial Fibrillation [ Time Frame: 12 months ]Any type of atrial fibrillation
- Heart failure [ Time Frame: 12 months ]Acute decompensated heart failure with or without cardiogenic shock
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03364387
|Contact: Oktay Ergene, Prof. Dr.||+90 232 - 2595959 - email@example.com|
|Contact: Mehdi Zoghi, Prof. Dr.||+90 232 -firstname.lastname@example.org|
|Contact: Emin Alioğlu, Assoc. Prof. Dr.|